Spanish Pharmaceuticals & Biotech Stable Growth Stocks

Almirall

Market Cap: €2.4b

Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.

Grifols

Market Cap: €6.1b

Engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally.